Using radiotracers to characterize magnetic resonance imaging contrast agents

Investigative Radiology

Volumn 37, Issue 3, 2002, Pages 107-113

  Tweedle, Michael F ^a  

^a Bracco Research USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CHELATING AGENT; CONTRAST MEDIUM; FERRIC OXIDE; FERRIDEX; FLUORINE; FLUORINE 18; GADODIAMIDE; GADOLINIUM 153; GADOLINIUM PENTETATE; GADOTERIC ACID; GADOTERIDOL; GADOVERSETAMIDE; IRON 59; MANGAFODIPIR; MANGANESE 54; MANGANESE CHLORIDE; PENTETIC ACID MN 54; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; DRUG DISTRIBUTION; EQUILIBRIUM CONSTANT; ISOTOPE LABELING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; SIGNAL NOISE RATIO;

EID: 0036125543     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200203000-00002     Document Type: Review

References (44)

1. 169Yb-DTPA compounds in brain sarcoma and kidneys of mice
2. Theory and practice of imaging easily saturated sites
3. True tracer radiolabeling of gadolinium complex of 10-(2-Hydroxpropyl)- 1,4,7,10-tetraazacyclododecane-1,4,7 triacetic acid (HP-DO3A)
4. First use of Gd DTPA/dimeglumine in man
5. Quantitative dependence of mr signal intensity on tissue concentration of Gd(HP-DO3A) in the nephrectomized rat
6. Preclinical evaluation of the pharmacokinetics, biodistribution and elimination of MS-325, a blood pool agent for magnetic resonance imaging
7. Ten precepts for quantitative data acquisition and analysis
8. Equilibrium. Transcytolemmal water-exchange kinetics in skeletal muscle in vivo
9. Iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review
10. Superparamagnetic agents in magnetic resonance imaging: Physicochemical characteristics and clinical applications. A review
11. Long circulating superparamagnetic particles with high T2 relaxivity
12. Superparamagnetic iron oxide nanoparticles as a liver MRI contrast agent: Contribution of microencapsulation to improved biodistribution
13. Iron oxide nanoparticles for use as an MRI contrast agent: Pharmacokinetics and metabolism
14. Biodegradation of magnetite dextran nanoparticles in the rat: A histologic and biophysical study
15. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging
16. Developmental toxicity of mangafodipir trisodium and manganese chloride in Sprague-Dawley rats
17. The effect of lipophilic substituents on the biological properties of EDTA complexes containing paramagnetic metal ions
18. Accumulation of manganese in the brain of mice after intravenous injection of manganese-based contrast agents
19. Regional distribution of manganese found in the brain after injection of a single dose of manganese-based contrast agents
20. The preliminary evaluation of Mn DTPA as a potential contrast agent for nuclear magnetic resonance imaging
21. Comparison of Fe-HBED and Fe-EHPG as hepatobiliary MR contact agents
22. Ferrioxamine B derivatives as hepatobiliary contrast agents for magnetic resonance imaging
23. Paramagnetic pyrophosphate. Preliminary studies on magnetic resonance contrast enhancement of acute myocardial infarction
24. Gd(III) chelates as MRI contrast agents: Structure, dynamics, and applications
25. Biodistributions of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate and gadodiamide in mice and rats
26. n in mice
27. Quantification of dechelation of gadopentetate dimeglumine in rats
28. Pharmacokinetics and tissue distribution in animals of gadobenate ion, the magnetic resonance imaging contrast enhancing component of gadobenate dimeglumine 0.5 M solution for injection (MulitHance)
29. Hepato-biliary and renal excretion in mice of charged and neutral gadolinium complexes of cyclic tetra-aza-phosphinic and carboxylic acids
30. A multi-organ, axially distributed model of capillary permeability for an MRI contrast agent
31. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat
32. 1
33. The interaction of gadolinium complexes with isolated rat hepatocytes
34. Pharmaceutical properties, biodistribution, and imaging characteristics of manganesemesoporphyrin
35. Hepatobiliary magnetic resonance contrast agents assessed by gadolinium-153 scintigraphy
36. Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9
37. Gallium-67/stable gadolinium antagonism: MRI contrast agent markedly alters the normal biodistribution of galluim-67
38. Metal ion speciation in blood plasma: Galluim-67-citrate and MRI contrast agents
39. Gallium-67/stable gadolinium antagonism
40. Can receptors be imaged with MRI agents?